Overview

Cardiox Liver Function Test Pivotal Trial

Status:
Withdrawn
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Performance evaluation of LFT Dye Monitor System using ICG - plasma disappearance rate value (PDR) to assess liver function in normal patients as well as in patients with mild to severe hepatic impairment compared to manual Serum ICG PDR.
Phase:
Phase 3
Details
Lead Sponsor:
Cardiox Corporation